Business
GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings
The collaboration with Amgen reduces out-of-pocket costs for patients and expands access to an innovative cholesterol-lowering therapy SANTA MONICA,
About this update from Goodrx Holdings, Inc.
[{"type":"text","content":"\nThe collaboration with Amgen reduces out-of-pocket costs for patients and expands access to an innovative cholesterol-lowering therapy\n\n\n SANTA MONICA, Calif.--(BUSINESS WIRE)--\nGoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of Repatha® (evolocumab), a cholesterol-lowering therapy, at a significantly reduced cash price. Starting today, patients can use GoodRx to access Repatha for $239 at more than 70,000 pharmacies nationwide, a savings of nearly 60% off the retail pharmacy list price.\n\n\n“In a healthcare system where affordability too often dictates access, GoodRx remains focused on delivering meaningful savings to patients at scale,” said Laura Jensen, Chief Commercial Officer and President of Pharma Solutions at GoodRx. “GoodRx is serving as the digital storefront to make Repatha more accessible for patients, leveraging our extensive retail pharmacy network to ensure it’s available where they already fill their prescriptions. This combination of meaningful savings and broad distribution helps break down barriers so patients can start and stay on the therapies that matter most for their health.”\n\n\nBy making Repatha accessible at a lower cash price than was previously available at retail, GoodRx and Amgen are helping patients bypass traditional insurance hurdles, such as restrictive formularies and high deductibles, that often delay or prevent treatment. GoodRx is pioneering direct-to-consumer solutions that give brands a trusted, scalable channel to deliver real savings directly to patients.\n\n\nThe $239 cash price for Repatha is available today at more than 70,000 pharmacies nationwide through GoodRx. Learn more at GoodRx.com/Repatha\n\n\nAdditional financial support information available at www.amgensupportplus.com/patient/repatha\n\n\nAbout GoodRx\n\n\nGoodRx is the leading platform for medication savings in the U.S., used by nearly 30 million consumers and over one million healthcare professionals annually. Uniquely situated at the center of the healthcare ecosystem, GoodRx connects consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies to make saving on medications easier. By reducing friction and inefficiencies, GoodRx helps consumers save time and money when filling prescriptions so they can get the car...